B. Strobel

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.

U. Deuschle, M. Trauner, P. Schwabl, 2017, Journal of hepatology.

The Guanylyl Cyclase Stlmulator Rloclguat Reduces Liver Fibrosis and Portal Pressure in Cirrhotic Rats

D. Bauer, M. Trauner, P. Schwabl, 2016 .

[Myoglobin-latex test. A new rapid test for the improvement of the early diagnosis of acute myocardial infarct].

M. Bachem, H. Keller, B. Strobel, 2008, Deutsche Medizinische Wochenschrift.

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.

U. Deuschle, M. Trauner, P. Schwabl, 2017, Journal of hepatology.

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

M. Trauner, P. Schwabl, C. Kremoser, 2015 .

G18 : The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

M. Trauner, P. Schwabl, C. Kremoser, 2015 .